Home/Filings/4/0001231919-03-000074
4//SEC Filing

HEALTHCARE VENTURES III L P 4

Accession 0001231919-03-000074

CIK 0000887137other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 12:07 PM ET

Size

11.4 KB

Accession

0001231919-03-000074

Insider Transaction Report

Form 4
Period: 2003-08-21
Transactions
  • Disposition to Issuer

    Common Stock

    2003-08-21994,0780 total
Footnotes (1)
  • [F1]The securities subject to this report were indirectly beneficially owned by HealthCare Partners III, L.P. ("HCPIII"), the General Partner of HealthCare Ventures III, L.P., and James H. Cavanaugh, Harold Werner, William Crouse, and John Littlechild, each of whom is a general partner of HCPIII and together were members of a Section 13(d) group that beneficially owned more than 10% of the Issuer's outstanding common stock. Mr. Littlechild is also a director of the Issuer. Dr. Cavanaugh and Messrs. Werner, Crouse and Littlechild disclaim beneficial ownership in those shares that they do not have a pecuniary interest. These shares were disposed of in connection with a merger agreement pursuant to which the Reporting Person received 1.5292 shares of GenVec, Inc. for each share of the Issuer.

Issuer

DIACRIN INC /DE/

CIK 0000887137

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0000886425

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 12:07 PM ET
Size
11.4 KB